Some will quit because the side effects, typically gastrointestinal symptoms like nausea and diarrhea, are too much to bear
The results in our study that were most analogous to RCT results were among the top 10% of treated respondents for weight loss (i.e., average reduction of 15% at 12 months) and HbA1c (i.e., average reduction of 3% at 12 months), while the bottom 10% of treated respondents saw no change or slightly worsening outcomes over time
These peptides stimulate your pituitary gland to produce more natural growth hormone, which then raises IGF-1
Notably, semaglutide and exenatide showed higher NAE proportions (16.97% and 14.44%, respectively) compared to tirzepatide (6.06%)
Targeted peptides may permit a quicker return of normal tissue function because they minimize collateral suppression of growth and repair signals
Examples of licensed GLP-1 receptor agonists available in the UK include semaglutide (Ozempic for diabetes